Tackling the 3 Leading Causes of Nonadherence: Fear, Cost, and Misunderstanding
PM 360,
Medication nonadherence costs the U.S. pharmaceutical industry an estimated $250 billion annually in potential revenue.
Medication nonadherence costs the U.S. pharmaceutical industry an estimated $250 billion annually in potential revenue.
7 hours ago 29 Views Higher rates of COVID-19 infection among essential and frontline workers put a spotlight on underinsured…
By Andre M. Perry, Joia Crear-Perry, Carl Romer, Nana Adjeiwaa-Manu Higher rates of COVID-19 infection among essential and…
People living in the United States have access to some of the best medical care in the world, from life-saving drugs to cutting-e…
How do doctors know if a new drug is really better than the ones already available? This is an important question because new…